Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

45 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: implications for timing to switch.
Tomasoni LR, Patroni A, Torti C, Paraninfo G, Gargiulo F, Quiros-Roldan E, Uccelli MC, Airò P, Tinelli C, Carosi G, Castelli F; Brescia-MASTER Study Group. Tomasoni LR, et al. Among authors: paraninfo g. HIV Clin Trials. 2003 Sep-Oct;4(5):311-23. doi: 10.1310/FGMF-Y0LY-DMX8-371V. HIV Clin Trials. 2003. PMID: 14583847
Exploratory analysis for the evaluation of lopinavir/ritonavir-versus efavirenz-based HAART regimens in antiretroviral-naive HIV-positive patients: results from the Italian MASTER Cohort.
Torti C, Maggiolo F, Patroni A, Suter F, Ladisa N, Paraninfo G, Pierotti P, Orani AM, Minoli L, Arici C, Sighinolfi L, Tinelli C, Carosi G; MASTER Cohort. Torti C, et al. Among authors: paraninfo g. J Antimicrob Chemother. 2005 Jul;56(1):190-5. doi: 10.1093/jac/dki172. Epub 2005 May 25. J Antimicrob Chemother. 2005. PMID: 15917286
Hyperbilirubinemia during atazanavir treatment in 2,404 patients in the Italian atazanavir expanded access program and MASTER Cohorts.
Torti C, Lapadula G, Antinori A, Quirino T, Maserati R, Castelnuovo F, Maggiolo F, De Luca A, Paraninfo G, Antonucci F, Migliorino G, Lazzarin A, Di Perri G, Rizzardini G, Esposito R, Carosi G. Torti C, et al. Among authors: paraninfo g. Infection. 2009 Jun;37(3):244-9. doi: 10.1007/s15010-008-8010-6. Epub 2009 May 26. Infection. 2009. PMID: 19471856
Long-term CD4+ T-cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non-NRTI or only NRTI.
Torti C, d'Arminio-Monforte A, Pozniak AL, Lapadula G, Cologni G, Antinori A, De Luca A, Mussini C, Castagna A, Cicconi P, Minoli L, Costantini A, Carosi G, Liang H, Cesana BM; MASTER, Chelsea & Westminster, ICONA, Modena and S. Raffaele HIV Cohorts. Torti C, et al. BMC Infect Dis. 2011 Jan 25;11:23. doi: 10.1186/1471-2334-11-23. BMC Infect Dis. 2011. PMID: 21266068 Free PMC article. Clinical Trial.
Prognostic factors correlated with survival in AIDS patients.
Casari S, Donisi A, Paraninfo G, Tomasoni D, Palvarini L, Nasta P, Bergamasco A, Cadeo GP, Carosi G. Casari S, et al. Among authors: paraninfo g. Eur J Epidemiol. 1999 Sep;15(8):691-8. doi: 10.1023/a:1007676625117. Eur J Epidemiol. 1999. PMID: 10555611
Evolution of antiretroviral prescription and response over a period of 8 years: an Italian multicentre observational prospective cohort study.
Sighinolfi L, Torti C, Zeni C, Ghinelli F, Suter F, Maggiolo F, Antinori A, Antonucci G, Castelnuovo F, Ladisa N, Migliorino M, Novati S, De Luca A, Lo Caputo S, Paraninfo G, Tinelli C, Carosi G; Italian MASTER Database Cohort. Sighinolfi L, et al. Among authors: paraninfo g. Infection. 2008 Jun;36(3):244-9. doi: 10.1007/s15010-007-7227-0. Epub 2008 May 3. Infection. 2008. PMID: 18454340
Evolution of transmitted HIV-1 drug resistance in HIV-1-infected patients in Italy from 2000 to 2010.
Colafigli M, Torti C, Trecarichi EM, Albini L, Rosi A, Micheli V, Manca N, Penco G, Bruzzone B, Punzi G, Corsi P, Parruti G, Bagnarelli P, Monno L, Gonnelli A, Cauda R, Di Giambenedetto S; ARCA, UCSC and Brescia HIV resistance study groups. Colafigli M, et al. Clin Microbiol Infect. 2012 Aug;18(8):E299-304. doi: 10.1111/j.1469-0691.2012.03847.x. Epub 2012 Apr 27. Clin Microbiol Infect. 2012. PMID: 22536753 Free PMC article.
Prevalence of drug resistance and newly recognised treatment-related substitutions in the HIV-1 reverse transcriptase and protease genes from HIV-positive patients naïve for anti-retrovirals.
Torti C, Bono L, Gargiulo F, Uccelli MC, Quiros-Roldan E, Patroni A, Paraninfo G, Tirelli V, Manca N, De Francesco MA, Perandin F, Carosi G. Torti C, et al. Among authors: paraninfo g. Clin Microbiol Infect. 2004 Sep;10(9):826-30. doi: 10.1111/j.1469-0691.2004.00938.x. Clin Microbiol Infect. 2004. PMID: 15355414 Free article.
45 results